Comtan · DIN 02243763 · 200 mg · tablet
Limited Use, Reason for Use code 367 requiredDormant since September 8, 2023 · checked November 19, 2026 · What does dormant mean?
StatusLimited Use, Reason for Use code 367 required
Write on scriptReason for Use code 367 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 367
Reason for Use code 367
For the treatment of patients with Parkinson's disease with 25% of the waking day in the off state despite maximally tolerated doses of levodopa.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Comtan · DIN 02243763
Manufacturer: Sandoz Canada Inc.; listing date 2003-04-16
Health Canada: Dormant since 2023-09-08 · brand COMTAN · ATC N04BX02 ENTACAPONE · form Tablet · route Oral · ingredients ENTACAPONE 200 MG · company Sandoz canada incorporated · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243763)
Source record
DIN 02243763: Comtan
Raw flags: sec12=Y, sec3=Y
Item: 289200014; group id 538; item number 1456; lccId 00142; manufacturer id SDZ
Source form: Tab; strength: 200mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.6837; ministry $0.4010
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243763
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67698
Interchangeable products
Mint-Entacapone · DIN 02535939 · $0.4010
Sandoz Entacapone · DIN 02380005 · $0.4010
Teva-Entacapone · DIN 02375559 · $0.4010
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since September 8, 2023 — choose a marketed DIN from the same-category list.